Meanings
- uncountablemedicineA medication belonging to the class of Janus kinase inhibitors, being developed as a drug to treat myelofibrosis.
Momelotinib is a JAK1/JAK2 inhibitor as well as an activin receptor–like kinase (ALK1) inhibitor. Because ALK1 is a receptor for bone morphogenic proteins, momelotinib is undergoing testing for the treatment of myelofibrosis (78).
2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2173
Cite this entry
momelotinib. (n.d.). In WatkinsX Dictionary. Retrieved November 4, 2026, from https://dictionary.watkinsx.com/word/momelotinib
“momelotinib.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/momelotinib. Accessed November 4, 2026.
WatkinsX Dictionary, s.v. “momelotinib,” accessed November 4, 2026, https://dictionary.watkinsx.com/word/momelotinib.
Source: momelotinib on Wiktionary, CC BY-SA 4.0.